Lineage Cell Therapeutics (LCTX) Shareholder's Equity (2010 - 2026)
Lineage Cell Therapeutics (LCTX) Shareholder's Equity (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn | 53.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.88 Mn |
| Dec 31, 2025 | 43.35 Mn |
| Sep 30, 2025 | 22.04 Mn |
| Jun 30, 2025 | 47.11 Mn |
| Mar 31, 2025 | 77.66 Mn |
| Dec 31, 2024 | 77.01 Mn |
| Sep 30, 2024 | 64.79 Mn |
| Jun 30, 2024 | 66.88 Mn |
| Mar 31, 2024 | 70.99 Mn |
| Dec 31, 2023 | 62.02 Mn |
| Sep 30, 2023 | 66.66 Mn |
| Jun 30, 2023 | 71.26 Mn |
| Mar 31, 2023 | 69.02 Mn |
| Dec 31, 2022 | 71.94 Mn |
| Sep 30, 2022 | 77.55 Mn |
| Jun 30, 2022 | 81.50 Mn |
| Mar 31, 2022 | 85.22 Mn |
| Dec 31, 2021 | 90.90 Mn |
| Sep 30, 2021 | 119.59 Mn |
| Jun 30, 2021 | 123.60 Mn |